TARS vs UPS · rev $183.0M vs P/E 15, rev $88.66B
Tarsus Pharmaceuticals Inc (TARS) versus United Parcel Service Inc (UPS) — a side-by-side from cached financials, not a winner call.
Tarsus Pharmaceuticals Inc (TARS) is a biotechnology company listed on NASDAQ.
United Parcel Service Inc (UPS) is a integrated freight & logistics company listed on US.
Latest reported TARS revenue for 2024-12-31 was $183.0M. Net income was -$115.6M. Revenue was up 948.6% from 2023-12-31 to 2024-12-31. TARS currently screens at market cap $2.66B.
Latest reported UPS revenue for 2025-12-31 was $88.66B. Net income was $5.57B. Revenue was down 2.6% from 2024-12-31 to 2025-12-31. UPS currently screens at market cap $85.76B and trailing P/E 14.8.
TARS currently screens at market cap $2.66B. UPS currently screens at market cap $85.76B and trailing P/E 14.8.
Not investment advice. Open the TARS and UPS stock pages for the full models.
Not investment advice.